Levo-transposition of the great arteries lab tests

Jump to navigation Jump to search

Levo-transposition of the great arteries Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Levo-transposition of the great arteries from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

Cardiac catheterization

ACC/AHA Guidelines for Clinical Evaluation and Follow Up

Treatment

ACC/AHA recommendations for surgical intervention
Post-operative care
Prevention
ACC/AHA recommendations for reproduction

Case Studies

Case #1

Levo-transposition of the great arteries lab tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Levo-transposition of the great arteries lab tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Levo-transposition of the great arteries lab tests

CDC on Levo-transposition of the great arteries lab tests

Levo-transposition of the great arteries lab tests in the news

Blogs on Levo-transposition of the great arteries lab tests

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Levo-transposition of the great arteries lab tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

Laboratory Findings

ACC/AHA guidelines recommend certain tests to evaluate and follow up in patients with levo-transposition of the great arteries

(ACC/AHA) recommendations for evaluation and follow-up of patients with congenitally corrected transposition of the great arteries (CCTGA) [1](DONOT EDIT)

Class I
1. All patients with CCTGA should have a regular follow-up with a cardiologist who has expertise in adult congenital heart disease (ACHD). (Level of Evidence: C)
2. Echocardiography-Doppler study and/or magnetic resonance imaging (MRI) should be performed yearly or at least every other year by staff trained in imaging complex congenital heart disease (CHD). (Level of Evidence: C)
3. The following diagnostic evaluations are recommended for patients with CCTGA:
a. Electrocardiogram (ECG). (Level of Evidence:C)
b. Chest X ray (Level of Evidence:C)
c. Echocardiography- Doppler (Level of Evidence:C)
d. MRI (Level of Evidence:C)
e. Exercise testing (Level of Evidence:C)

References

  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.

Template:WH Template:WS